首页> 外文OA文献 >Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy
【2h】

Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy

机译:C5取代的嘧啶无环核苷的氨基磺酸盐前药用于抗病毒治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acyclic nucleoside phosphonates (ANPs) are nowadays one of the key drugs in the treatment of DNA virus and retrovirus infections. In this work, we report the synthesis and antiviral evaluation of phosphonoamidate and diamidates prodrugs of C5-pyrimidine acyclic nucleosides derivatives functionalized with but-2-enyl- chain. In the phosphonoamidate series, the most active compound 15, showed sub-micromolar activity against varicella zoster virus (VZV) (EC50 = 0.09-0.5 μM) and μM activity against human cytomegalovirus (HCMV) and herpes simplex virus (HSV). Separation of single diastereoisomers for compound 14, showed that 14b had better anti-herpesvirus activity and no cytotoxicity compared to the diastereoisomeric mixture 14. Very interestingly, phosphonodiamidate 21 showed anti-herpesvirus activity with excellent activity against wild type and thymidine kinase-deficient (TK(-)) VZV strains (EC50 = 0.47 and 0.2 μM, respectively) and HCMV (EC50 = 3.5-7.2 μM) without any cytotoxicity (CC50 > 100).
机译:无环核苷膦酸酯(ANP)是当今治疗DNA病毒和逆转录病毒感染的关键药物之一。在这项工作中,我们报告了C5-嘧啶无环核苷衍生物正丁-2-烯基链功能化的氨基磷酸酯和二酰胺酸盐前药的合成和抗病毒评价。在磷酸氨基酰胺系列中,活性最高的化合物15对水痘带状疱疹病毒(VZV)(EC50 = 0.09-0.5μM)具有亚微摩尔活性,对人巨细胞病毒(HCMV)和单纯疱疹病毒(HSV)具有μM活性。化合物14的单一非对映异构体的分离显示,与非对映异构体混合物14相比,14b具有更好的抗疱疹病毒活性且无细胞毒性。非常有趣的是,膦酰二酰胺21显示了抗疱疹病毒活性,对野生型和胸苷激酶缺陷型(TK (-))VZV株(分别为EC50 = 0.47和0.2μM)和HCMV(EC50 = 3.5-7.2μM)没有细胞毒性(CC50> 100)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号